$VIR
Vir Biotechnology, Inc. Common Stock
XNAS
Why is VIR down today? It is at $8.87 (-2.63%), and our scanner flagged it 33 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VIR spikes, and full due diligence on VIR — key stats, earnings, dilution and insider activity. Free.
Get free $VIR alerts the moment volume spikes
Our scanner flagged $VIR 33 times in the last 30 days. Create a free account to track $VIR, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $8.87
- Change today
- -2.63%
- Previous close
- $9.11
- 52-week range
- $4.16 – $11.66
- Market cap
- $1.54B
- Dividend yield
- 1.10% ($0.10)
- Institutional own.
- 91.82%
- Total held
- 94.6%
- Tradeable float
- 9.1M 5% of shares · after 3% insiders + 92% institutions
- Avg daily volume
- 2.1M
- Exchange
- XNAS
- 5m
- 0.0x
- 15m
- 0.4x
- 1h
- 0.8x
- 1D
- 0.1x
Get free VIR + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $VIR down today?
Here is the latest on VIR from our scanner (live price and day move above). Fresh from the SEC: Vir Biotechnology, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystQuarterly report (10-Q), from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying7 buys, 2 sells last 3 months (14/53 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Coughlin Timothy Director | Acquired (grant/award) | +16K | n/a | 16K | n/a | Jun 9, 26 |
Sabatini Brent Officer | Sold (automatic/other) | -379 | sold 0.6% | 62K | $4K at $9.45 | Jun 1, 26 |
Napolitano Janet Director | Sold (automatic/other) | -3K | sold 13% | 21K | $30K at $9.45 | Jun 1, 26 |
Bischofberger Norbert W Director | Acquired (grant/award) | +8K | added 60% | 21K | n/a | May 27, 26 |
Farid Ramy Director | Acquired (grant/award) | +8K | added 33% | 32K | n/a | May 27, 26 |
Hatfield Jeffrey S. Director | Acquired (grant/award) | +8K | added 25% | 40K | n/a | May 27, 26 |
More Robert J Director | Acquired (grant/award) | +8K | added 20% | 49K | n/a | May 27, 26 |
Napolitano Janet Director | Acquired (grant/award) | +8K | added 49% | 24K | n/a | May 27, 26 |
Sigal Charles Elliott Director | Acquired (grant/award) | +8K | added 25% | 40K | n/a | May 27, 26 |
Sato Vicki L Director | Sold (automatic/other) | -22K 0.01% of company | sold 2.0% | 1.08M | $221K at $10.05 | May 1, 26 |
De Backer Marianne Officer | Sold (automatic/other) | -234K 0.1% of company | sold 25% | 715K | n/a | Apr 29, 26 |
De Backer Marianne Officer | Acquired (grant/award) | +234K 0.1% of company | added 100% | 287K | n/a | Apr 29, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $VIR runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $8.50/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$VIR Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$VIR Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
VIR stock FAQ
Why is $VIR down today?
Here is the latest on VIR from our scanner (live price and day move above). Fresh from the SEC: Vir Biotechnology, Inc. filed a Quarterly report (10-Q). A material company disclosure like this is often the real catalyst behind a move of this size.
What is the VIR stock price today?
VIR last traded at $8.87, down 2.63% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Does VIR pay a dividend?
Yes. VIR currently has a dividend yield of about 1.10% ($0.10 per share per year). Dividend figures can change; this is not investment advice.
Where can I see live VIR alerts?
The VIR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VIR 33 times in the last 30 days.
What exchange is VIR on?
VIR (Vir Biotechnology, Inc. Common Stock) trades on XNAS, with a market cap of about $1.54B.
Is VIR good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VIR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.